JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

JANX is currently covered by 13 analysts with an average price target of $32.17. This is a potential upside of $22.09 (219.15%) from yesterday's end of day stock price of $10.08.

Our record on Janux Therapeutics covers 16 analysts since 2008; 11 cover it today. Of the 75 price targets those analysts set on JANX, 26 were reached (35%). The highest performance score on Janux Therapeutics belongs to George Farmer of Scotiabank: 7.10, with 2 of 4 targets met in 8 days on average. The latest calls: Robert Driscoll of Wedbush raised the target to $40 from $36 with a Buy rating on 6 Nov 2026; Etzer Darout of Barclays raised the target to $15 from $14 with a Sell rating on 6 Nov 2026; Bradley Canino of Guggenheim cut the target to $55 from $58 with a Buy rating on 7 Aug 2026. Figures as of 18 Nov 2026.

Janux Therapeutics's activity chart (see below) currently has 75 price targets and 82 ratings on display. The stock rating distribution of JANX is 96% BUY and 4% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 24.26% of the time, taking 132.81 days on average.

Highest price target for JANX is $55, Lowest price target is $12, average price target is $32.17.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 06-Nov-2026. First documented stock forecast 06-Jul-2021.

Currently out of the existing stock ratings of JANX, 24 are a BUY (96%), 1 are a SELL (4%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Apr-2023

$40

$29.92 (296.83%)

$36

16 days ago
(06-Nov-2026)

6/12 (50%)

$22.37 (126.89%)

204

Sell Since 06-Nov-2026

$15

$4.92 (48.81%)

$14

16 days ago
(06-Nov-2026)

2/5 (40%)

$-2.63 (-14.92%)

14

Buy Since 25-Jun-2026

$27

$16.92 (167.86%)

$26

16 days ago
(06-Nov-2026)

0/2 (0%)

$9.37 (53.15%)

Buy Since 07-Nov-2025

$35

$24.92 (247.22%)

$38

3 months 13 days ago
(09-Aug-2026)

0/3 (0%)

$19.15 (120.82%)

Buy Since 05-Sep-2024

$55

$44.92 (445.63%)

$58

3 months 15 days ago
(07-Aug-2026)

0/7 (0%)

$39.15 (247.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 133 days for the stock forecasts to be reached, with an average price target met ratio of 24.26%.

Which analyst most recently updated their price target on JANX (Janux Therapeutics)?

Robert Driscoll

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Robert Driscoll works at WEDBUSH and has 16 price targets and 13 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Justin Zelin with the highest potential upside of $89.92

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Joshua Schimmer with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?